欢迎您！东篱公司
退出
-
申报数据库
-
立项数据库
-
成果数据库
-
项目获奖数据库
中文摘要：
哺乳动物雷帕霉素靶蛋白（ mammalian target of rapamy-cin, mTOR）是衰老和衰老相关疾病的一个关键调节因子。雷帕霉素（ rapamycin, RAPA）可通过抑制mTOR通路,诱导和促进细胞自噬的发生。细胞自噬是维持细胞内稳态的主要方式与途径,通过降解多余的、受损的及衰老的蛋白与细胞器,为细胞重建、再生和修复提供必需原料。早老症（ hutchinson-gil-ford progeria syndrome, HGPS ）患者细胞中伴随早老蛋白（ progerin）的异常聚集；此外,诸如亨廷顿病、帕金森病、阿尔茨海默病等神经退行性疾病细胞内同样出现异常蛋白质的聚集,而这些异常蛋白的清除正依赖干细胞的自噬作用。由此可见,雷帕霉素是潜在的抗衰老、治疗早老症及衰老相关疾病的重要药物。该文主要阐述雷帕霉素促进细胞自噬方面的功能及在HGPS、神经退行性疾病方面的应用。
英文摘要：
Mammalian target of rapamycin（ mTOR） is a key reg-ulator of aging and aging-related diseases. Rapamycin （ RAPA） induces and promotes the process of cell autophagy through in-hibiting mTOR pathway. Autophagy exerts a crucial role in main-taining the cellular meostasis, which provides essential materials for cell reconstruction, regeneration and repair via degradating the redundant, damaged, or senescent proteins and organelles. Hutchinson Gilford progeria syndrome （ HGPS ） patients are al-ways accompanied with abnormally accumulated progerin in cells. Similar to HGPS, abnormal protein accumulation is the common pathological feature of neurodegenerative diseases, in-cluding Huntington′s disease, Parkinson′s disease, Alzheimer′s disease and so on. Degradation of these abnormal proteins pre-dominantly depends on cell autophagy. Thus, rapamycin is a po-tential anti-aging drug for HGPS and aging-related diseases thera-py. This view focuses on the effects of rapamycin on cell autoph-agy and clinical application in HGPS and neurodegenerative dis-eases.
同期刊论文项目
同项目期刊论文
MicroRNA transcriptome analysis identifies miR-365 as a novel negative regulator of cell proliferati
PMT1 deficiency enhances basal UPR activity and extends replicative lifespan of Saccharomyces cerevi
CIA2 deficiency results in impaired oxidative stress response and enhanced intracellular basal UPR a
Investigation into the antibacterial activity of monodisperse BSA-conjugated zinc oxide nanoparticle
期刊信息
位置：